Post-transcriptional control of gene expression Flashcards
RNA purification for RNA:protein ints
- synthesise biotinyllated oligo
- incubate with proteins
- recover RNA:protein complexes with streptavidin beads
- detect bound proteins by WB
Protein purification for for RNA:protein ints
- analogous to ChIP: purify protein with RNAs using antibodies
- generate cDNAs from mRNAs using reverse transcriptase
- detect cDNA of interest by PCR
Cross-linking RNA and proteins for RNA:protein ints
stabilise ints by crosslinking with UV light
3 parts of eukaryotic mRNA processing
5’ capping
removal of introns (splicing)
3’ polyadenylation
function of mRNA 5’ cap
increase splicing efficiency
need for export to cytoplasm
need for efficient translation initiation
protect mRNA from 5’ exonucleases
5’ cap formation
- remove terminal phosphate from DNA 5’ end by RTPase (RNA terminal phosphatase)
- GMP transferred from GTP by RNA guanylyl transferase (RGTase), gives G5’ppp5’N
- guanine is methylated by RNA-(guanine-N-7)-methyltransferase. = cap 0. further mods in mammals
- RTPase and RGTase are part of same polypeptide in multicellular orgs
early, cotranscriptional event
nuclear cap bound by CBC, cap-binding complex
specificity of 5’ capping
- all and only pol II transcripts
- only di-/ tri- phosphate ends
- cotranscr, by factors associated w pol II CTD
pol II a CTD
- heptad tandem repeats
- residues that can be phosphorylated
- close to RNA exit channel of pol II
- initiation: dephosph
- elongation: early S5 phosph, later S2 phosph
CTD = landing platform for cotranscriptional factors
experiment that shows pol II CTD needed for capping
- cells transfected witha version of amanitin resistant RNAP II
- one version has normal length CTD, one version has fewer repeats
- inhibit endogenous RNAP II with amanitin (so see activity of mutant only)
- quantify capped and uncapped mRNAs
- fewer capped mRNAs produced with mutant CTD than WT
2 experiments to show capping enzymes associate w phosphorylated pol II CTD
1
pass nuclear extract thr affinity column, WT CTD/ mutant CTD/ phosphorylated CTD
- measure capping act in each of samples retained
- only retained in column w phosph CTD
2
fission yeast: make CTD that cannot be phosph at S5, replace endogenous gene w mutant - no cell growth
fuse mammalian capping enzyme to CTD - rescues mutation
5’ cap structure
N7 methyl guanosine, attached to mRNA 5’ through 5’-5’ triphosphate bond
pol II transcription termination
doesn’t terminate at precise positions
evidence for run-on transcription
incubate nuclei with NTPs + radioactive UTP. RNAs are completed, cleaved and hybridised to DNA probes spaced along the gene and downstream regions
==> radioactive signal continues downstream of mature 3’ mRNA end, signal decreases in 5’ to 3’ direction
structure of polyA tail
many A residues, shortened as mRNA ages so linked to RNA decay
functions of polyA tail
protection from 3’ exonucleases, control degradation rate, need for transcr initiation
cis sequences needed for polyadenylation
AAUAAA upstream of cleavage site
U// GU rich DSE downstream of cleavage site
how was polyadenylation shown to occur in 2 stages
- cleavage needs AAUAAA, 10 As are added
- polyA doesn’t need AAUAAA but does need 10 As, longer polyA tail added
2 stages of polyadenylation
- cleavage
- polyadenylation
trans factors needed for polyadenylation
- CPSF = cleavage polyadenylation specificity factor, binds AAUAAA and CStF, need for both cleavage and polyadenylation
- CStF = cleavage stimulation factor, binds GU/ U, need for cleavage only
- polyA polymerase adds A residues, also need for cleavage
(identified by MS)
evidence that 3’ end processing is cotranscriptional
mutant CTD cells are defective in 3’ end processing
CPSF and CStFbind CTD in affinity columns
example of alternative polyadenylation
Sex-Lethal (SXL) in drosophila: RBP expressed only in females, regulates polyadenylation
target: e(r), has 2 alternative polyadenylation sites. males use first site, females use second
females: SXL binds e(r) premRNA and competes w CStF for binding first GU element - so second site used. in males, CStF binds proximal site.
importance: female specific 3’ UTR has transcriptional repression sequences so e(r) not produced.
genome-wide view of polyadenylation
- high throughput seq: fragment RNAs, purify fragments w polyA, sequence and identify those w boundary betw polyA and gene sequence
3’ end processing assay
incubate RNA substrate with nuclear extracts and ATP
- presence of ATP:cleavage, polyA
- ddATP: cleavage but not polyA
- RNA that mimics cleaved substrate is polyAed.
discovery of splicing: R loop analysis
- hybridise mRNA to dsDNA in conditions that favour RNA:DNA interactions, 1 DNA strand displaced = R loop
- visualise by EM: can distinguish single vs double strands by width
- use on adenovirus DNA: mRNA had tails protruding on both ends. 3’: polyA, 5’ unexplained
- 5’ anneals the mRNA from a separate part of the genome, mRNA=composite
cis elements for splicing
- 5’ splice site consensus
- most introns start w GU and end with AG (GU/AG rule)
- 3’ end: branch point consensus with conserved adenine, polypyrinidine tract downstream of branchpoint
3’ splice site = YAG
trans factors for splicing
snRNPs = smalll nuclear RiboNucleoProteins: RNA associated w protein, RNA = functional
U1 snRNP: basepairs with 5’ splice site
U2 snRNP: basepairs with branchpoint
U2AF: U2 auxiliary factor (protein). large 65 subunit binds polypyrimidine tract, 35 subunit binds 3’ splice site.
splicing: mutations
mutation within consensus sequence can inactivate splicing/ use cryptic splice sites
mutation outside of consensus - no effect
5’ SS/ branchpoint mutations can be reversed by complementary mutations in U1/ U2 = evidence for base pairing
in vitro analysis of splicing
- synthesise splicing substrate (2 exons, 1 intron)
- incubate radiolabelled RNA w nuclear extracts, ATP
- take samples at intervals, analyse RNA by denaturing electrophoresis, autoradiography
debranching - normal migration of previously circular intermediates
see product acc over time
chemistry of splicing
2x transesterification
- 2’ hydroxyl of A of branchpoint attacks phosphate at 5’ of intron, 5’ exon released and lariat formed
- 3’ hydroxyl of 5’’ exon attacks phosphate at 3’ of intron. exons are ligated, intron released as lariat. lariat then degraded.
splicing code
will a splice site be used?
splicing enhancers and repressors form splicing code, regulates efficiency of splice site usage
introns often contain regulatory sequences as well as core splice sites
will a splice site be used?
- strength - similarity to consensus
- enhancers/ repressors with bound proteins
- RNA secondary str
alternative splicing - why?
pairing dif combos of splice sites - tissue specific/ developmental specific differences
- regulation of gene expr
- different protein isoforms
most human genes
alternative splicing: drosophila SXL
SXL expressed in females but not males: include exon 3 in males, includes a stop codon so no SXL produced.
skip exon 3 in females so can produce ful length protein
exon 3 = ‘poison exon’
so control gene expression
alternative splicing: drosophila DSCAM
many mutually exclusive exons
38k possible isoforsm (more than drosophila genes!)
protein variability for recognition of specific neurones
splicing and genetic disease
many genetic conditions causes by mutations affecting splice sites, eg inactivation/ generating new, regulatory regions
eg HGPS: a silent point mutation activates a cryptic splice site, creates a protein with a deletion lacking a protease cleavage site, incorrectly processed.
splicing: ATP
actual chemistry: no ATP needed as number of phosphodiester bonds conserved.
ATP needed for spliceosome assembly
translation cycle - what happens in each stage
initiation - recognise initiation codon … up to first peptide bond formation
elongation - formation of all peptide bonds
termination - release of polypeptide, ribosome dissociation
stages of translation cycle
- small subunit then large associates with mRNA
- can associate without mRNA, dissociation factor binds and prevents this reassociation to form an inactive complex. (IF3/ e-IF3) - released in initiation
tRNA binding sites of ribosome
A: aminoacyl-tRNA
P: peptidyl-tRNA
E: exit from ribosome
what is needed for prokaryotic translation initiation (7)
- mRNA with RBS
- ribosomes
- initiator tRNA
3 IFs: - IF1: bind A site, prevent tRNA access
- IF2: complexes with initiator tRNA and GTP
- IF3: dissociation factor
- GTP
prokaryotic translation initiation
- IF1 and IF3 bind the 30S subunit, this then binds mRNA at the RBS
- IF2 forms a ternary complex with GTP and charged initiator tRNA. joins the 30S, forming 30S initiation complex
- 50S joins, GTP hydrolysis by IF2 and all IFs released. 70S initiation complex